Skip to main content


Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Association between sodium glucose co-transporter 2 inhibitors and a reduced risk of heart failure in patients with type 2 diabetes mellitus: a real-world nationwide population-based cohort study

Fig. 2

Kaplan–Meier plots of hospitalization for heart failure in all patients (a) and baseline cardiovascular stratifications (b with baseline cardiovascular disease, c without baseline cardiovascular disease). DPP-4i dipeptidyl-peptidase IV inhibitor, N number, SGLT-2i sodium-glucose co-transporter 2 inhibitor, y year(s)

Back to article page